Surgery Partners (SGRY) PT Lowered to $28 at Mizuho
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts SGRY Hot Sheet
Price: $23.25 +0.52%
Rating Summary:
8 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Rating Summary:
8 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Join SI Premium – FREE
Mizuho analyst Ann Hynes lowered the price target on Surgery Partners (NASDAQ: SGRY) to $28.00 (from $35.00) while maintaining a Outperform rating.
You May Also Be Interested In
- SGRY Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Surgery Partners to HealthSpan Partners
- Camtek (CAMT) PT Lowered to $140 at Stifel
- Livanova (LIVN) PT Raised to $115 at Mizuho
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
